Theriva Biologics, Inc. Payments to Acquire in Process Research and Development
Theriva Biologics, Inc. (TOVX) reported Payments to Acquire in Process Research and Development of $441.00 thousand for the 0-month period ending 2018-09-05, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2020-02-20
- Theriva Biologics, Inc. payments to acquire in process research and development for fiscal 2016 was $643.00K, a 51.65% increase from fiscal 2015.
- Theriva Biologics, Inc. payments to acquire in process research and development for fiscal 2015 was $424.00K, a 44.71% increase from fiscal 2014.
- Theriva Biologics, Inc. payments to acquire in process research and development for fiscal 2014 was $293.00K, a 70.70% decline from fiscal 2013.
- Theriva Biologics, Inc. payments to acquire in process research and development for fiscal 2013 was $1.00M, a 1049.43% increase from fiscal 2012.
| Period end | Payments to Acquire in Process Research and Development 0 month | Payments to Acquire in Process Research and Development 0 month as first filed | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|
| 2018-09-05 | $441.00K 10-K · filed 2020-02-20 | $321.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $643.00K 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $424.00K 10-K · filed 2019-02-27 | ||
| 2014-12-31 | $293.00K 10-K · filed 2017-03-02 | ||
| 2013-12-31 | $1.00M 10-K · filed 2016-03-10 | ||
| 2012-12-31 | $87.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |